If I understood this correctly, SI mentioned that positive results of this trial (being a fully randomised trial) may help to alleviate some of the concerns that the FDA had with the GVHD trial. There were "very strong signals" for the under 65 age group and MSB are in ongoing discussions with the FDA regarding GVHD.
Ann: COVID ARDS Trial Topline 60-Day Results, page-51
-
- There are more pages in this discussion • 1,578 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.49 |
Change
0.140(10.4%) |
Mkt cap ! $1.701B | |||
| Open | High | Low | Value | Volume |
| $1.37 | $1.54 | $1.37 | $23.10M | 15.82M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 24758 | $1.49 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.49 | 73626 | 3 |
View Market Depth
| Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |